Calista Ming, OD, FAAO, FSLS, provides 3 cases of how to fit specialty lenses at the right time for patients.

Outlook Therapeutics seeks FDA clarity on ONS-5010 after a complete response letter, aiming to address efficacy concerns for wet AMD treatment.

The optometric giant recently passed away at the age of 97.

The company stated that the distinguishing feature of the new Ahmed ClearPath ST is its smaller tube lumen.

Naureen Haroon, OD, MPH, FAAO, founder of the newly formed WHSIG, said the group's primary aim is to educate the optometric community about why certain eye conditions disproportionately affect women.

Dry eye specialists weigh in on what role dry eye plays in their practices.

The research, published in JAMA Health Forum, examined 950 AIMDs approved by the US Food and Drug Administration as of November 2024.

Understanding the scale and scope, by the numbers.

The latest in drug and technology developments and updates from August 2025.

Catch up on the top stories in optometry during the week of August 25-August 29.

In this podcast, experts John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; and John Hovanesian, MD, FACS; discuss the importance of comprehensive strategies when performing corneal sensitivity testing in patients suspected of having neurotrophic keratitis (NK).

Vision insurance coverage was also noted in the report as higher among younger and higher-income Canadians.

The Japan’s Ministry of Health, Labor, and Welfare approved the lens for manufacturing and sale in the country.

FDA issues a complete response letter to Outlook Therapeutics for ONS-5010, citing insufficient evidence of effectiveness for wet AMD treatment.

As many as 9 in 10 providers report tariffs having most strongly impacted wholesale eyewear prices, with 8 out of 10 stating that tariffs are affecting wholesale practice supplies.